AAM
PRVL

Alpine Associates Management’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Alpine Associates Management’s Portfolio PRVL Stock Details PRVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-857,705
Closed -$19.8M – 63
2020
Q4 		$19.8M Buy
+857,705
New +$19.8M 0.81% 29